Latest filingAug 21, 2026Most recent Form 4
MANE
Veradermics, Inc
NYSEHealthcarePharmaceutical Preparations
Insider activity for last month from 08/03 to 09/03. Counts use processed Form 4 rows. Purchase and sale metrics use codes P and S; totals remain unknown when any matching value is missing. Rows without a usable transaction date cannot be assigned to a rolling period and are excluded.
Total buying$00 buys
Total selling$9.24B12 sells
Net open-market-$9.24B6 insiders
Open-market mix
Buy vs sell distribution by transaction countInsider activity report
Monthly open-market purchase and sale counts Buys Sells
Transaction codes
By Form 4 transaction code in selected period20transactions
- S · Open-market sells · dominant12 · 60%
- M · Option exercise4 · 20%
- X · Derivative exercise4 · 20%
Activity by reported role
A joint filing can contribute to multiple roles26transactions
- Chief executive officer · dominant7 · 27%
- CTO7 · 27%
- Director6 · 23%
- SF6 · 23%
Distinct insiders active
Reporting-owner CIKs by month · peak Aug 2026 (6)Aug 2026Sep 2026
Reported Holdings After
Separated by insider, security, and ownership typeWaldman Reid AlexanderCommon Stock · Direct
226,797Aug 17, 2026
Durso Timothy AugustCommon Stock · Direct
113,724Aug 17, 2026
Montanova Capital, LlcCommon stock, par value $0.00001 per share · Indirect · See footnotes
3,106,937Aug 20, 2026
Cowen AaronCommon stock, par value $0.00001 per share · Indirect · See footnotes
3,106,937Aug 20, 2026
Averill Master Fund, Ltd.Common stock, par value $0.00001 per share · Indirect · See footnotes
3,106,937Aug 20, 2026
Averill Madison Master Fund, Ltd.Common stock, par value $0.00001 per share · Indirect · See footnotes
612,033Aug 20, 2026
Montanova Capital, LlcPre-Funded Warrants · Indirect · See footnotes
0Aug 20, 2026
Cowen AaronPre-Funded Warrants · Indirect · See footnotes
0Aug 20, 2026
These are reported post-transaction holdings, not company-wide ownership percentages. Securities, indirect vehicles, and amendments are kept separate.
Filing activity heatmap
Each cell is one day · intensity = transactions · buys green, sells redAug 03 → Sep 03
LessMore
Top insiders
By absolute net value across the selected period- ML-$80.4M
- WA-$7.2M
- DA-$4.6M
Recent filing activity
Most recent 12 transactions · color = transaction codeFiling detail checks
Secondary metrics for the selected periodFiling-only signals
Deterministic matches in the selected period
MANE transaction history
Filters apply within this company and selected period by default| Ticker | Insider | Role | Type | Shares | Value | Code | Signals | 90d return | Filed | Trans date |
|---|---|---|---|---|---|---|---|---|---|---|
| MANE | MONTANOVA CAPITAL, LLC | DIR | exercise | 151k | $0 | X | −4.8% | 08/21 | 08/20 | |
| MANE | MONTANOVA CAPITAL, LLC | DIR | exercise | 149k | $0 | X | −4.8% | 08/21 | 08/20 | |
| MANE | MONTANOVA CAPITAL, LLC | DIR | exercise | 151k | — | X | — | −4.8% | 08/21 | 08/20 |
| MANE | MONTANOVA CAPITAL, LLC | DIR | exercise | 149k | — | X | — | −4.8% | 08/21 | 08/20 |
| MANE | MONTANOVA CAPITAL, LLC | DIR | sale | 59.3k | -$637M | S | −4.8% | 08/21 | 08/19 | |
| MANE | MONTANOVA CAPITAL, LLC | DIR | sale | 690k | -$7.40B | S | −4.8% | 08/21 | 08/19 | |
| MANE | Durso Timothy August | CTO | exercise | 3.45k | $0 | M | −12.3% | 08/19 | 08/17 | |
| MANE | Durso Timothy August | CTO | sale | 161 | -$1.79M | S | −12.3% | 08/19 | 08/17 | |
| MANE | Durso Timothy August | CTO | sale | 2.34k | -$25.6M | S | −12.3% | 08/19 | 08/17 | |
| MANE | Durso Timothy August | CTO | sale | 16.7k | -$181M | S | −12.3% | 08/19 | 08/17 | |
| MANE | Durso Timothy August | CTO | sale | 16.3k | -$175M | S | −12.3% | 08/19 | 08/17 | |
| MANE | Durso Timothy August | CTO | sale | 7.91k | -$84.4M | S | −12.3% | 08/19 | 08/17 | |
| MANE | Durso Timothy August | CTO | exercise | 3.45k | $4.20M | M | −12.3% | 08/19 | 08/17 | |
| MANE | Waldman Reid Alexander | CEO | exercise | 3.45k | $0 | M | −12.3% | 08/19 | 08/17 | |
| MANE | Waldman Reid Alexander | CEO | sale | 249 | -$2.77M | S | −12.3% | 08/19 | 08/17 | |
| MANE | Waldman Reid Alexander | CEO | sale | 3.00k | -$32.8M | S | −12.3% | 08/19 | 08/17 | |
| MANE | Waldman Reid Alexander | CEO | sale | 27.4k | -$298M | S | −12.3% | 08/19 | 08/17 | |
| MANE | Waldman Reid Alexander | CEO | sale | 25.2k | -$271M | S | −12.3% | 08/19 | 08/17 | |
| MANE | Waldman Reid Alexander | CEO | sale | 11.5k | -$123M | S | −12.3% | 08/19 | 08/17 | |
| MANE | Waldman Reid Alexander | CEO | exercise | 3.45k | $4.20M | M | −12.3% | 08/19 | 08/17 |
Veradermics, Inc Insider Activity FAQ
SEC Form 4 contextWho recently reported transactions at Veradermics, Inc?
Averill Madison Master Fund, Ltd., Averill Master Fund, Ltd., Cowen Aaron, MONTANOVA CAPITAL, LLC, Durso Timothy August, Waldman Reid Alexander.
When was the latest reported open-market purchase?
No code-P purchase is available for this period.
When was the latest reported open-market sale?
Montanova Capital, Llc reported a sale on Aug 19, 2026 valued at $637M. Read the SEC filing.
What is the recent purchase and sale balance?
Net open-market selling in the selected period was $92,408,217.44. Sales can occur for many non-investment reasons.
Where can I see the original SEC filing?
Every transaction row and latest-activity fact links to its original SEC filing.
What do these Form 4 transaction codes mean?
P and S generally describe open-market or private purchases and sales. A, D, F, M, X, G, J, and V describe awards, issuer dispositions, tax withholding, exercises, gifts, other transactions, and voluntary early reports; review each filing and its footnotes for context.